Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary highlights a 21% YoY increase in deliveries, strong partnerships, and a positive cash flow. Despite some uncertainties in timelines and impacts, the Q&A section reveals improved supply chains, tariff exemptions, and optimistic growth projections. The positive factors, such as potential billion-dollar deals in India and strong margins, outweigh the uncertainties, leading to a positive rating.
Executive Aviation Revenue $750 million in Q4 2025, a 25% year-over-year increase. The increase was driven by higher volumes, pricing, and operating leverage, which offset the negative impact of U.S. tariffs.
Commercial Aviation Revenue 7% year-over-year increase in 2025, driven by higher volumes. Adjusted EBITDA margin improved from 2.5% to 2.7% due to lower expenses.
Defense & Security Revenue 36% year-over-year increase in 2025, driven by higher KC-390 and A-29 Super Tucano volumes. Adjusted EBITDA margin improved from 6.2% to 7.9% due to operating leverage and client mix.
Service and Support Revenue 18% year-over-year increase in 2025, driven by higher volumes and the ramp-up of the OGMA GTF engine shop. Adjusted EBITDA margin decreased from 16.5% to 15.5% due to the ramp-up of new operations.
Adjusted Free Cash Flow $491 million in 2025, compared to $676 million in 2024. The decrease was due to a one-off $150 million inflow in 2024 related to the Boeing agreement. Exceeded guidance of $200 million or higher due to reduced working capital requirements.
Adjusted Net Income $253 million in 2025, compared to $461 million in 2024. The decline was mainly due to a one-time $150 million impact from the Boeing agreement, less favorable net results, and U.S. import tariffs.
Backlog $31.6 billion in Q4 2025, a 20% year-over-year increase. Commercial Aviation backlog increased by 42%, Defense & Security by 10%, Service and Support by 7%, and Executive Aviation by 3%.
Revenue $7.6 billion in 2025, an 18% year-over-year increase. Q4 2025 revenue was nearly $3 billion, a 15% year-over-year increase. Growth was driven by diversified business segments.
Adjusted EBITDA $889 million in 2025 with an 11.7% margin, compared to 12.1% in 2024. The decrease was due to U.S. import tariffs and infrastructure-related costs.
Aircraft Deliveries 91 aircraft in Q4 2025 (32 commercial jets, 53 executive jets, 6 defense-related), a 21% year-over-year increase. Full-year deliveries included 78 commercial jets (7% increase) and 155 executive jets (20% increase).
E2 Program: Strong sales across all continents, consolidating the E2 platform as a benchmark in the small narrow-body segment.
Executive Aviation: Revenues reached an all-time high of $750 million in Q4 2025, with 53 business jets delivered, the highest number ever in a single quarter.
eVTOL Prototype: First flight in December 2025, with 28 missions completed and certification expected in 2027.
Next Generation Praetor 500E and 600E: Announced as part of the Executive Aviation portfolio.
Global Partnerships: Strategic partnerships under discussion with Mahindra and Adani Group in India and Northrop Group in the U.S., supporting growth in Commercial Aviation and Defense segments.
Defense & Security Orders: Sweden ordered 4 KC-390s with 90 options, and Portugal signed a 6-aircraft order with 10 options for NATO countries.
Production Chain Improvements: Closer collaboration with suppliers, process digitalization, and investments in AI tools extended across all platforms to support production stability in 2026 and beyond.
Revenue Growth: Achieved double-digit revenue growth over the past three years despite supply chain challenges.
Backlog Growth: Company-wide backlog reached $31.6 billion, up 20%, with significant increases in Commercial Aviation (+42%) and Defense & Security (+10%).
Book-to-Bill Ratio: Consolidated ratio of 1.7:1 in 2025, indicating strong sales momentum across all business units.
Supply Chain Challenges: Despite achieving revenue growth, the company faced ongoing supply chain challenges, which could impact production stability and delivery timelines.
U.S. Import Tariffs: The company faced a $27 million impact from U.S. import tariffs in Q4 2025, which negatively affected margins and profitability.
Infrastructure Costs: Nonrecurring infrastructure-related costs of $20 million in Q4 2025 weighed on margins, highlighting potential risks in managing operational expenses.
Economic Volatility: The company acknowledged challenges and volatility in the broader economic environment, which could impact financial performance and operational stability.
Certification Delays: The eVTOL program's certification is targeted for 2027, and any delays in this timeline could hinder the company's strategic objectives in the urban air mobility market.
Debt Management: Although the company improved its debt maturity profile, the average cost of debt remains a factor to monitor, especially in volatile financial markets.
Production Stability: Production level initiatives have been extended across all platforms to support production stability in 2026 and onwards.
Strategic Partnerships: Partnerships under discussion with global players in India (Mahindra and Adani Group) and the U.S. (Northrop Group) are expected to reinforce strategic positions and support long-term growth potential in Commercial Aviation and Defense segments.
eVTOL Certification: The eVTOL program is advancing through flight tests towards certification in 2027.
2026 Guidance - Aircraft Deliveries: Commercial Aviation is forecasted to deliver between 80 and 85 aircraft, and Executive Aviation is forecasted to deliver 160 to 170 jets, representing a year-over-year increase of approximately 6% in both segments.
2026 Guidance - Revenue: Revenue is estimated to settle between $8.2 billion and $8.5 billion, with the midpoint of the range 10% higher than 2025.
2026 Guidance - EBIT Margin: EBIT margin is forecasted between 8.7% and 9.3%, implying around $750 million at the midpoint of the range, approximately 15% higher than the adjusted $657 million EBIT generated in 2025.
2026 Guidance - Free Cash Flow: Adjusted free cash flow without Eve is estimated at $200 million or higher for 2026.
Midterm Free Cash Flow Goal: The midterm goal is to convert 50% of EBITDA into free cash flow, with an expected generation of approximately $1.4 billion or more from 2024 to 2026.
Market Position and Backlog: The backlog reached $31.6 billion, with approximately $20 billion in customer options, representing potential for significant expansion over the coming years.
Shareholder remuneration: Declared a total of BRL 568 million in 2025 in shareholder remuneration, combining interest in equity and dividend. This amount corresponded to BRL 0.78 per share and represents a dividend yield of approximately 0.9%. An additional dividend will be paid to ensure compliance with the minimum 25% net income distribution required under Brazilian corporate law. The full amount will be paid in a single installment following the 2026 Annual Shareholders Meeting.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.